Health Fitness And Beauty Secrets Your Guide For Better Health

Image Source - which.co.uk Which? research shows that some supplement manufacturers are making misleading claims on their products - as a result, people could be wasting money on unnecessary food supplements. Other manufacturers use clever language and font sizes to exaggerate the effect that some ingredients have. So although only a small minority of people actually need supplements, a third of adults in our survey told us they regularly take them. The supplements industry was valued at £385 million in 2012. Misleading claims The most popular supplements people take are multivitamins, glucosamine supplements for joint health, and probiotic tablets and drinks. However, all health claims relating to glucosamine and joint health have been rejected by the EU. Claims that probiotics improve digestive health were also rejected. In the past five years, products (food, drink and supplements) that want to carry a health claim have had to submit the evidence behind that claim to the EU's Eu

What is Joint Stimuflex? Stimuflex is a joint supplement that gives you fast relief from your joint pains. The product is of high quality and can be safely recommended. This product may seem relatively more expensive than other supplements but that is only because of its high quality. Joint Stimuflex Manufacturer Whole Body Research is the manufacturer of Joint Stimuflex. The company uses all-natural ingredients to produce top quality products which are tested by a third party, and offer guaranteed results. The company also has an excellent customer support service. Joint Stimuflex Ingredients This supplement has a greater amount of active ingredients than other pain relief supplements. This is why it is so effective. It contains: Turmeric White willow bark Eggshell membrane Boswellia Turmeric is a natural anti-inflammatory that helps to greatly reduce joint pain due to swelling. The eggshell membrane is known to be very effective in reducing joint pains. The active ingredients are us

London, United Kingdom (PRWEB UK) 3 December 2013 FLEXISEQ's proven efficacy comes with significant advantages as the product has no contra-indications, contains no drugs so cannot cause drug-to-drug interactions, and with over 6 million doses administered since launch there have been no reported systemic side effects. FLEXISEQ is already successfully sold in the early pilot markets of Austria, Germany, Ireland, Malaysia and Singapore. Earlier this year, FLEXISEQ won the Innovation Award 2013 from the Federal Association of German Pharmacists. In June, FLEXISEQ launched in Ireland and became the fastest growing over-the-counter product that pharmacies there had seen in recent times. UK Charity Launch John Mayo, Chairman and Chief Executive of Pro Bono Bio said "I am proud to bring the world's first clinically proven nano-physical product for pain relief to the UK. For the UK Charity launch period, FLEXISEQ is exclusively available online via the Arthritis Research UK websi